Rigel Pharmaceuticals CMO Wolfgang Dummer resigns, effective March 31, 2023

RIGEL PHARMACEUTICALS INC

Wolfgang Dummer, EVP and Chief Medical Officer, will resign effective March 31, 2023.
Company has initiated a search for a new CMO with substantial hematology-oncology experience.
Dummer will continue in his role through the separation date and receive severance under the Executive Severance Plan.
Resignation deemed a Non-COC Qualifying Termination; requires full release of claims.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Wolfgang Dummer

Executive Vice President and Chief Medical Officer

RIGL · RIGEL PHARMACEUTICALS INC

Effective: 2023-03-31
Filed: February 3, 2023, 6:59 PM ET

Wolfgang Dummer, M.D., Ph.D. informed Rigel Pharmaceuticals, Inc. (the “Company”) of his intention to resign from his position as the Company’s Executive Vice President and Chief Medical Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wolfgang Dummer resigned as Executive Vice President and Chief Medical Officer at RIGEL PHARMACEUTICALS INC.

Action: resigned
Role: Executive Vice President and Chief Medical Officer

Exact text from the filing

Wolfgang Dummer, M.D., Ph.D. informed Rigel Pharmaceuticals, Inc. (the “Company”) of his intention to resign from his position as the Company’s Executive Vice President and Chief Medical Officer.

View on SEC.gov

RIGEL PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-23-010536

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.